Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Jonathan S. Zager reports grants from Amgen, Delcath Systems, Philogen, and Provectus; grants and personal fees from Castle Biosciences and Novartis; and personal fees from Pfizer, Merck, and Sun Pharma. Alexander van Akkooi reports advisory board and consultancy honoraria (all paid to institute and unrelated to current work) from Amgen, Bristol- Myers Squibb, Novartis; 4SC, Merck–Pfizer, MSD–Merck, Sanofi, and Sirius medical. The remaining authors made no disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stahlie, E.H.A., Carr, M.J., Zager, J.S. et al. ASO Visual Abstract: External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort. Ann Surg Oncol 29, 1647–1648 (2022). https://doi.org/10.1245/s10434-021-11143-2
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11143-2